Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progression.

Autor: Bartels, Stephan1 (AUTHOR) bartels.stephan@mh-hannover.de, Vogtmann, Julia1 (AUTHOR), Schipper, Elisa1 (AUTHOR), Büsche, Guntram1 (AUTHOR), Schlue, Jerome1 (AUTHOR), Lehmann, Ulrich1 (AUTHOR), Kreipe, Hans1 (AUTHOR)
Zdroj: European Journal of Haematology. Apr2021, Vol. 106 Issue 4, p520-528. 9p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje